Výsledky vyhledávání

Aminoglutethimide in advanced breast cancer: plasma levels and clinical results after low and high doses

Autor: Carlo Maurizio Camaggi, Andrea Martoni, Elena Strocchi, S. Miseria, G. Robustelli Della Cuna, M. Balli, Ettore Bichisao, G. Bonciarelli, G. Ambroso, P. Malacarne, M. Indelli, Franco Pannuti, R. Cellerino

Publikováno v: Cancer Chemotherapy and Pharmacology. 27:451-455

Drug plasma levels, metabolism data and clinical results were evaluated after the daily administration of either 500 or 1,000 mg aminoglutethimide (AG, Orimeten, Ciba-Geigy) plus hydrocortisone acetate (20 mg b. i. d.). A total of 34 patients with ad

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64226c65868d959be0237141dd13b9d7
https://doi.org/10.1007/bf00685159

Zobrazit plný text záznamu

Impact of delirium on the short term prognosis of advanced cancer patients. Italian Multicenter Study Group on Palliative Care

Autor: A, Caraceni, O, Nanni, M, Maltoni, L, Piva, M, Indelli, E, Arnoldi, M, Monti, L, Montanari, D, Amadori, F, De Conno

Publikováno v: Cancer. 89(5)

The objective of this study was to evaluate the impact of delirium on the survival of advanced cancer patients also assessed with a validated prognostic score (the palliative prognostic [PaP] score).The study population was a prospective multicenter

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::6392b3d69950406eb3a21f49070bf64e
https://pubmed.ncbi.nlm.nih.gov/10964345

Zobrazit plný text záznamu

Intravenous itasetron: establishing the effective dose range for the prophylactic control of acute emesis in cancer patients undergoing high-dose cisplatin chemotherapy

Autor: P. Malacarne, D. Donati, R. Kempe, M. Indelli, T. Voigt, M. A. Palladino, A. Giglietti, A. Del Favero, P. Cigarini, G. Bensi, L. Patoia

Publikováno v: Clinical oncology (Royal College of Radiologists (Great Britain)). 11(2)

Nausea and vomiting induced by chemotherapy are a major cause of distress to patients and reduce compliance with potentially beneficial treatment. Itasetron hydrochloride is a new 5-hydroxytryptamine3 (5-HT3) antagonist with potent antiemetic propert

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdb4768103c0e97f2f70f92f4b962e61
https://pubmed.ncbi.nlm.nih.gov/10378635

Zobrazit plný text záznamu

Successful validation of the palliative prognostic score in terminally ill cancer patients. Italian Multicenter Study Group on Palliative Care

Autor: M, Maltoni, O, Nanni, M, Pirovano, E, Scarpi, M, Indelli, C, Martini, M, Monti, E, Arnoldi, L, Piva, A, Ravaioli, G, Cruciani, R, Labianca, D, Amadori

Publikováno v: Journal of pain and symptom management. 17(4)

The aim of this work was to validate a previously constructed prognostic score for terminally ill cancer patients in order to determine its value in clinical practice. The Palliative Prognostic Score (PaP Score) was tested on a population of 451 eval

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::48c77c233f59c55c9b85ed6ffd1eb630
https://pubmed.ncbi.nlm.nih.gov/10203876

Zobrazit plný text záznamu

A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. Italian Multicenter and Study Group on Palliative Care

Autor: M, Pirovano, M, Maltoni, O, Nanni, M, Marinari, M, Indelli, G, Zaninetta, V, Petrella, S, Barni, E, Zecca, E, Scarpi, R, Labianca, D, Amadori, G, Luporini

Publikováno v: Journal of pain and symptom management. 17(4)

In recent years, extensive research has been performed to identify prognostic factors that predict survival in terminally ill cancer patients. This study describes the construction of a simple prognostic score based on factors identified in a prospec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9c1578a51c17f1a0a12194aee11355a9
https://pubmed.ncbi.nlm.nih.gov/10203875

Zobrazit plný text záznamu

Biological indices predictive of survival in 519 Italian terminally ill cancer patients. Italian Multicenter Study Group on Palliative Care

Autor: M, Maltoni, M, Pirovano, O, Nanni, M, Marinari, M, Indelli, A, Gramazio, E, Terzoli, M, Luzzani, F, De Marinis, A, Caraceni, R, Labianca

Publikováno v: Journal of pain and symptom management. 13(1)

The knowledge of prognostic factors capable of subdividing cancer patients into groups having homogenous survival times is useful even in very advanced stages of illness. This prospective multicenter study assessed these prognostic factors in 530 ter

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::cf23711daf202c4c1bb3d10f16cb7353
https://pubmed.ncbi.nlm.nih.gov/9029856

Zobrazit plný text záznamu

Prediction of survival of patients terminally ill with cancer. Results of an Italian prospective multicentric study

Autor: M, Maltoni, M, Pirovano, E, Scarpi, M, Marinari, M, Indelli, E, Arnoldi, M, Gallucci, L, Frontini, L, Piva, D, Amadori

Publikováno v: Cancer. 75(10)

The individualization of prognostic factors in the various stages of cancer facilitates the planning of a therapeutic assistance program aimed at various subsets of patients. The prognostic factors for survival in patients terminally ill with cancer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4656d66245183289d648934329a590a0
https://pubmed.ncbi.nlm.nih.gov/7537625

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání